|
HY-109066-1mL
|
MedChemexpress LLC
|
Olinciguat [CAS 1628732-62-6] (10mM in DMSO)
|
|
COVID-19-immunoregulation
|
|
|
HY-18874-1mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-10mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-100mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-25mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-5mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-50mg
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3]
|
|
|
|
|
HY-18874-1mL
|
MedChemexpress LLC
|
p38-Alpha MAPK-IN-1 [CAS 443913-15-3] (10mM in DMSO)
|
|
|
|
|
HY-133530-10mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-100mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-25mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-5mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-50mg
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0]
|
|
|
|
|
HY-133530-1mL
|
MedChemexpress LLC
|
PDD00017238 [CAS 1952247-05-0] (10mM in DMSO)
|
|
|
|
|
HY-133531-10mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-100mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-25mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-5mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-50mg
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8]
|
|
|
|
|
HY-133531-1mL
|
MedChemexpress LLC
|
PDD00017272 [CAS 1945950-20-8] (10mM in DMSO)
|
|
|
|
|
HY-123812-1mg
|
MedChemexpress LLC
|
PF-03654764 [CAS 935840-35-0]
|
|
COVID-19-immunoregulation
|
|
|
HY-122026-10mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-100mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-25mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
|
HY-122026-5mg
|
MedChemexpress LLC
|
PF-04802367 [CAS 1962178-27-3]
|
|
Neuroscience-Neurodegeneration
|
|
